Condition (MeSH)
Paranoid Disorders
ClinicalTrials.gov lists 19 trials for Paranoid Disorders or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
19 of the 19 trials are tagged with Paranoid Disorders itself; the rest are tagged with a narrower condition beneath it.
When did Paranoid Disorders trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2012 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 22 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 33 months across 13 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Paranoid Disorders trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Not applicable | 14 |
| Observational | 1 |
How many Paranoid Disorders trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 5 |
| Enrolling by invitation | 1 |
| Completed | 13 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Paranoid Disorders trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AstraZeneca | 1 |
| Novartis Pharmaceuticals | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| AZD 8529 | 1 |
| Intranasal Oxytocin Spray | 1 |
| Routine Care | 1 |
| TAU | 1 |
| Cognitive Remediation | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Paranoid Disorders trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Suicidal ideation | 2 | 1 |
| Serious Adverse Events | 0 | 1 |
Which publications cover Paranoid Disorders? (43)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Transcranial Direct Current Stimulation Improves Paranoia and Social Functioning in Schizophrenia: A Randomized Clinical Trial. | Biological psychiatry | 2025 | Yes |
| Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial. | Nature medicine | 2025 | Yes |
| The revised Green <i>et al.</i>, Paranoid Thoughts Scale (R-GPTS): psychometric properties, severity ranges, and clinical cut-offs. | Psychological medicine | 2021 | Yes |
| The Dunn Worry Questionnaire and the Paranoia Worries Questionnaire: new assessments of worry. | Psychological medicine | 2020 | Yes |
| The relationship between insecure attachment and paranoia in psychosis: A systematic literature review. | The British journal of clinical psychology | 2020 | Yes |
Showing 5 of 43 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.